Technology
BofA says LSE Group shares trading at 'material discount'
Analysts at Bank of America reiterated their 'buy' recommendation for shares of LSE Group, telling clients that the business's fundamentals were underpinned by "long-term secular trends" which in turn supported its high-quality growth on the topline.
Destiny Pharma loss widens as it extends cash runway
Biotechnology company Destiny Pharma reported a loss before tax of £7. 7m in its 2022 results on Thursday, widening from £6. 3m in the prior year.
LendInvest pleased with performance in tough financial year
Lending platform operator LendInvest reported 20. 5% growth in platform assets under management in a full-year trading update on Thursday, and 6. 4% growth in the second half.
Crimson Tide reports solid 2022 financial, operational performance
Crimson Tide reported a solid financial and operational performance in its unaudited preliminary results for 2022 on Wednesday.
Cambridge Cognition wins two contracts worth £2.1m
Brain health technology specialist Cambridge Cognition has won two contracts worth more than £2. 1m, it announced on Wednesday.
Bytes appoints Sam Mudd to executive director role
Software, security, and cloud services provider Bytes Technology Group announced the appointment of Sam Mudd as an executive director on Wednesday, effective after its annual general meeting (AGM) to be held in July.
LBG Media ends 2022 in 'strong' position
Digital publisher LBG Media said in its full-year results on Wednesday that, despite a challenging economic environment, it ended 2022 with a strong performance, significant growth in its global audience and content views, and continued expansion of brand partnerships.
J.P. Morgan says recent run in technology shares 'becoming stretched'
Analysts at J. P. Morgan cautioned clients on Tuesday that the recent run in the Technology space was becoming "stretched" in absolute terms.
Spectral MD to trade on Nasdaq through SPV merger plans
Artificial intelligence (AI) medical diagnostics developer Spectral MD announced plans on Tuesday to combine with Rosecliff Acquisition Corp I - a special purpose acquisition company listed on Nasdaq.
Seed Innovations completes sale of Leap Gaming
Seed Innovations announced the completion of the sale of its portfolio company Fralis, also known as Leap Gaming, to IMG Arena US on Tuesday.
Unikmind updates acceptance levels in bid for Kape Technologies
Unikmind updated the market on acceptances of its cash offer to acquire Kape Technologies on Tuesday, reporting that as of 6 April, it had received acceptances over 160,678 Kape shares, or 0. 03% of its issued ordinary share capital.
Ilika ships first batch of Stereax batteries to Blink Energy
Solid-state battery technology specialist Ilika announced the shipment of its first batch of ‘Stereax’ batteries on Tuesday, to its customer, Blink Energy.
Malvern reports post-Covid bounce-back across programmes
Learning and skills development specialist Malvern International reported a 169% surge in revenues in its final results on Thursday, to £6. 51m.
Avacta doses first patient in higher-dose oncology cohort
Life sciences company Avacta Group announced that it had dosed the first patient in the fifth cohort of the first-in-human phase one trial of its innovative oncology drug ‘AVA6000’ on Wednesday.
Zoo Digital acquires remaining 49pc of Korea operation
Localisation and media service specialist Zoo Digital announced the acquisition of the remaining 49% stake in Zoo Korea on Wednesday, having acquired a majority 51% equity in March last year.
QinetiQ inks 10-year renewal with UK Submarine Delivery Agency
QinetiQ Group announced the renewal of its Maritime Strategic Capability Arrangement (MSCA) with the Submarine Delivery Agency on Wednesday, for a further 10 years.
Peel Hunt stays at 'buy' on Renewi, highlights net debt reduction
Analysts at Peel Hunt reiterated their 'buy' recommendation for shares of Renewi following the company's pre-close trading update, noting how net debt continued to reduce.
Gooch & Housego reports positive trading in first half
Specialist photonic components and systems manufacturer Gooch & Housego reported positive trading in a first-half update on Tuesday.
Destiny Pharma upbeat on infection prevention study
Destiny Pharma said in an update on Tuesday that its novel medicine for preventing life-threatening infections, ‘NTCD-M3’, had been shown to colonise the gut successfully in a C difficile infection (CDI) model study after the administration of fidaxomicin.
Proteome Sciences reports solid growth in 2022
Biotechnology company Proteome Sciences reported total revenues of £7. 78m in its final results on Tuesday - a significant year-on-year increase from £5. 13m.